Oxygen Biotherapeutics’ oxygen therapy products in development for traumatic brain injury, stroke, heart attack, and many other biomedical applications


Guests: Dr. Chris Stern, Chairman and CEO, and Deb Thompson, Sr. VP Clinical Affairs, Oxygen Biotherapeutics, Inc., Durham

sternphoto.jpg
Dr. Chris Stern, Chairman & CEO, Oxygen Biotherapeutics, Inc.
thompsonphoto.jpg
Deb Thompson, Sr. VP, Clinical Affairs, Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc.

DERMACYTE Oxygen Concentrate Gel

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s